Piper Jaffray Upgrades Pacific Biosciences of California (PACB) to Neutral
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.32 -5.71%
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Piper Jaffray upgraded Pacific Biosciences of California (NASDAQ: PACB) from Underweight to Neutral with a price target of $3.10 (from $2.00).
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $2.67 yesterday.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $2.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Upgrades BWX Technologies (BWXT) to Buy
- Barclays Upgrades Enphase Energy (ENPH) to Equalweight
- Citi Upgrades Mercari, Inc (4385:JP) (MRCIF) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
